4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001441876-26-000002
Options or other derivatives
- Director acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ronaghi Mostafa Director | 2026-01-02 | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | D | ||
Loading xslF345X05/wk-form4_1767743091.xml…